• Reset
578 results
Born in the USA: The Newest SARS-CoV-2 Variant
Oct 29, 2021

Reviewed by Erica Stohs, MD, MPH, University of Nebraska Medical Center  Following the recent COVID-19 surge in Southern California, investigators identified a novel SARS-CoV-2 variant,…

First Do No Harm: Antibiotic Risks in Pediatric Inpatients

Reviewed by Zach Willis, MD, MPH, University of North Carolina  Same and colleagues reviewed 400 consecutive antibiotic courses in pediatric inpatients and assessed the incidence…

Noses everywhere rejoice! Saliva now listed as a comparable alternative sample type to nasopharyngeal swab

Reviewed by Dr. Michael Payne, MD, London Health Sciences Centre  Nasopharyngeal swabs/nasal swabs are the most common sample type for COVID-19 PCR testing. However, saliva…

Stay on Guard: Lessons from a SARS-CoV-2 Nosocomial Outbreak

Reviewed by Clare Marlin, MS, BSN, CIC, Shirley Ryan AbilityLab and James “Brad” Cutrell, MD FIDSA, UT Southwestern Medical Center  In this report from Klompas…

Always Be Prepared: Supporting Successful PPE Stockpiling Systems

Reviewed by Clare Marlin, MS, BSN, CIC, Shirley Ryan AbilityLab Careful inventory tracking and maintenance of personal protective equipment (PPE) supplies in stockpiles for emergent…

Pre-transplant testing: A cautionary tale

Reviewed by Hannah Imlay, MD, MS, University of Utah This case report describes transmission of SARS-CoV-2 from a lung donor unrecognized to have SARS-CoV-2 to…

What works in ASP? Time to Step up Our Game

Reviewed by Cynthia T. Nguyen, PharmD, University of Chicago Medicine and James “Brad” Cutrell, MD, FIDSA, UT Southwestern Medical School As the threat of antimicrobial…

Social Determinants of Health are Painfully Clear in COVID-19 Testing Resources and Outcomes

Reviewed by Rebekah Moehring, MD, MPH, FSHEA, Duke University Anyone working in infectious diseases epidemiology has learned long ago that infections are a social disease,…

Cefiderocol: Does a new drug bring new successes?

Reviewed by Hannah Imlay, MD, MS, University of Utah Two recent trials have refined the role of cefiderocol in clinical practice and shaped IDSA recommendations…

A Little Ceftriaxone Goes a Long Way: Third-Generation Cephalosporin Exposure and Risk of Subsequent Resistance among Potential AmpC Producers

Reviewed by Zach Willis, MD, MPH; University of North Carolina, Chapel Hill, NC Stultz and colleagues analyzed urinary and respiratory isolates of possible AmpC producers…

News from the Frontlines: Implementing an IPC program for a COVID-19 surge facility

Reviewed by Clare Marlin, MS, BSN, CIC; Shirley Ryan AbilityLab Tadavarthy and colleagues implemented an infection prevention and control (IPC) program, including thorough training in…

“The Variants Are Coming”: Emergence of SARS-CoV-2 Variant Lineages in the United States

Reviewed by James “Brad” Cutrell, MD FIDSA; UT Southwestern Medical School Much of the public health and epidemiology community’s attention has shifted to the new…

  1. 1
  2. ...
  3. 32
  4. 33
  5. 34
  6. ...
  7. 49
We use cookies to help improve your experience
Ok